NCT07168915View on ClinicalTrials.gov

A Study of V118E in Healthy Participants (V118E-003)

PHASE1RecruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

October 8, 2025

Primary Completion Date

April 8, 2027

Study Completion Date

April 8, 2027

Conditions
Healthy
Interventions
BIOLOGICAL

V118E

IM administration

BIOLOGICAL

PREVNAR 20™

IM administration

BIOLOGICAL

Saline

IM administration

Trial Locations (1)

33009

RECRUITING

Velocity Clinical Research, Hallandale Beach ( Site 0003), Hallandale

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT07168915 - A Study of V118E in Healthy Participants (V118E-003) | Biotech Hunter | Biotech Hunter